Gene Symbol | C17orf51 |
---|---|
Entrez Gene | 339263 |
Alt Symbol | - |
Species | Human |
Gene Type | protein-coding |
Description | chromosome 17 open reading frame 51 |
Other Description | uncharacterized protein C17orf51 |
Swissprots | B2RN29 A8MQB3 B5MCL4 |
Accessions | A8MQB3 AK023039 AK056436 BAG51708 AK090937 AK096256 AK123143 BC010612 BC019938 BC040371 BC052777 BC053952 BC132738 AAI32739 BC136630 AAI36631 BX640850 XM_005256621 XP_005256678 XM_006721514 XP_006721577 XM_011523822 XP_011522124 XR_243554 NM_001113434 NP_001106905 |
C17orf51 CRISPR/Cas9 KO Plasmid (h) - sc-415509 from Santa Cruz Biotechnology
|
||||||||
C17orf51 HDR Plasmid (h) - sc-415509-HDR from Santa Cruz Biotechnology
|
||||||||
C17orf51 Double Nickase Plasmid (h) - sc-415509-NIC from Santa Cruz Biotechnology
|
||||||||
C17orf51 Double Nickase Plasmid (h2) - sc-415509-NIC-2 from Santa Cruz Biotechnology
|
||||||||
C17orf51 CRISPR Activation Plasmid (h) - sc-415509-ACT from Santa Cruz Biotechnology
|
||||||||
C17orf51 CRISPR Activation Plasmid (h2) - sc-415509-ACT-2 from Santa Cruz Biotechnology
|
||||||||
C17orf51 Lentiviral Activation Particles (h) - sc-415509-LAC from Santa Cruz Biotechnology
|
||||||||
C17orf51 Lentiviral Activation Particles (h2) - sc-415509-LAC-2 from Santa Cruz Biotechnology
|
||||||||
C17orf51 siRNA (h) - sc-93876 from Santa Cruz Biotechnology
|
||||||||
C17orf51 shRNA Plasmid (h) - sc-93876-SH from Santa Cruz Biotechnology
|
||||||||
C17orf51 shRNA (h) Lentiviral Particles - sc-93876-V from Santa Cruz Biotechnology
|
||||||||
MISSION® esiRNA - EHU221921 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN4460 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND4460 from Sigma-Aldrich
|
||||||||
C17orf51 siRNA (Human) - CRJ7278 from Cohesion Biosciences
|
||||||||
C17orf51 - MBS8210984 from MyBioSource
|
||||||||
shRNA set against Human C17orf51 (NM_001113434.3) - SHH249846 from Creative biogene
|
||||||||
C17orf51 shRNA Plasmid (Human) - CHJ7278 from Cohesion Biosciences
|
||||||||